Pfizer 1 XNB (Inlyta 1 mg)
Generic Name: axitinib
Pill with imprint Pfizer 1 XNB is Red, Elliptical / Oval and has been identified as Inlyta 1 mg. It is supplied by Pfizer Inc..
Inlyta is used in the treatment of renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Inlyta 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer 1 XNB
Inlyta
- Generic Name:
- axitinib
- Imprint:
- Pfizer 1 XNB
- Strength:
- 1 mg
- Color:
- Red
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
VEGF/VEGFR inhibitors - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Pfizer Inc.
- National Drug Code (NDC):
- 00069-0145
- Inactive Ingredients:
-
- microcrystalline cellulose
- lactose monohydrate
- croscarmellose sodium
- magnesium stearate
- titanium dioxide
- triacetin
- ferric oxide red
- hypromellose 2910 (15000 mPa.s)
Note: Inactive ingredients may vary.
More about Inlyta (axitinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: multikinase inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
